Velarion Records
Free. Unsubscribe any time.

Vir Biotechnology, Inc. (VIR)

Vir Biotechnology, Inc. filed 43 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 8 reporting owners, covering 58 transactions and 3,426,812 shares. None carries the SEC's AFF10B5ONE flag; all 43 name a plan in a footnote. 8 results prints are on file in the same window.

What stands out

Trades in Vir Biotechnology, Inc. 58

Adoption dates in Vir Biotechnology, Inc. 9

Results prints in Vir Biotechnology, Inc. 8

Trades before a print in Vir Biotechnology, Inc. 10

Interval to Vir Biotechnology, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Vir Biotechnology, Inc. states

Filing text: “10b5-1 trading plan adopted by the Reporting Person on March 27, 2025”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.